blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2422774

EP2422774 - Pharmaceutical composition containing a tetrahydrofolic acid [Right-click to bookmark this link]
StatusPatent revoked by proprietor
Status updated on  19.05.2016
Database last updated on 25.09.2024
Most recent event   Tooltip04.08.2017New entry: Loss of particular rights: legal effect 
Applicant(s)For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Strasse 10
40789 Monheim / DE
[2015/33]
Former [2012/39]For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Strasse 10
40789 Monheim / DE
Former [2012/09]For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
Inventor(s)01 / King, Christina
Schönhauser Allee 73 F
D-10437 Berlin / DE
 [2012/24]
Former [2012/09]01 / King, Christina
Dunckerstrasse 26
10437 Berlin / DE
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[N/P]
Former [2012/41]Plougmann & Vingtoft A/S
Rued Langgaards Vej 8
2300 Copenhagen S / DK
Former [2012/39]Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [2012/09]Plougmann & Vingtoft A/S
Sundkrogsgade 9 P.O. Box 831
2100 Copenhagen Ø / DK
Application number, filing date11190550.129.06.2007
[2012/09]
Priority number, dateEP2006001400206.07.2006         Original published format: EP 06014002
[2012/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2422774
Date:29.02.2012
Language:EN
[2012/09]
Type: B1 Patent specification 
No.:EP2422774
Date:12.08.2015
Language:EN
[2015/33]
Search report(s)(Supplementary) European search report - dispatched on:EP12.01.2012
ClassificationIPC:A61K9/20, A61K31/585, A61K31/567, A61K31/525, A61P15/18
[2012/09]
CPC:
A61K9/2054 (EP); A61K31/525 (KR,RU); A61K31/57 (KR);
A61K31/585 (KR,RU); A61K9/2018 (EP); A61P15/00 (EP);
A61P15/18 (EP); A61P5/30 (EP); A61P5/34 (EP);
A61K31/565 (RU); A61K31/567 (RU); A61K9/20 (RU) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/09]
Extension statesAL24.11.2011
BA24.11.2011
HR24.11.2011
MK24.11.2011
RS24.11.2011
TitleGerman:Pharmazeutische Zusammensetzung enthaltend eine Tetrahydrofolsäure[2012/09]
English:Pharmaceutical composition containing a tetrahydrofolic acid[2012/09]
French:Composition pharmaceutique contenant un acide tetrahydrofolique[2012/09]
Examination procedure24.11.2011Examination requested  [2012/09]
29.08.2012Amendment by applicant (claims and/or description)
31.10.2014Communication of intention to grant the patent
27.01.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.02.2015Communication of intention to grant the patent
29.06.2015Fee for grant paid
29.06.2015Fee for publishing/printing paid
29.06.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07764936.6  / EP2040683
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070764936) is  17.11.2009
Opposition(s)Opponent(s)01  12.05.2016  12.10.2016  INADMISSIBLE
Laboratorios Léon Farma, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Opponent's representative
Schön, Christoph, et al, et al
Dr. Schön, Neymeyr & Partner mbB
Bavariaring 26
80336 München / DE
 [2016/52]
Former [2016/34]
Opponent(s)01  12.05.2016    INADMISSIBLE
Laboratorios Léon Farma, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Opponent's representative
Schön, Christoph, et al, et al
Dr. Schön, Neymeyr & Partner mbB
Bavariaring 26
80336 München / DE
10.08.2016Despatch of communication of loss of particular rights: opposition inadmissible 01
12.08.2016No. 01: Notification indicating deficiencies in the notice of opposition
20.08.2016Despatch of communication of loss of particular right
07.10.2016No. 01: Reply to notification indicating deficiencies in the notice of opposition
Revocation procedure08.04.2016Request for revocation under Article 105a
 ADMISSIBLE
20.05.2016Despatch of communication that patent will be revoked
15.06.2016Date of legal effect of revocation of patent
08.04.2016Fee for revocation paid
Former [2016/24]08.04.2016Request for revocation under Article 105a
 ADMISSIBLE
15.06.2016Date of legal effect of revocation of patent
08.04.2016Fee for revocation paid
Fees paidRenewal fee
24.11.2011Renewal fee patent year 03
24.11.2011Renewal fee patent year 04
24.11.2011Renewal fee patent year 05
13.06.2012Renewal fee patent year 06
10.06.2013Renewal fee patent year 07
12.06.2014Renewal fee patent year 08
10.06.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.08.2015
BE12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
[2017/07]
Former [2017/03]AT12.08.2015
BE12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/36]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/23]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/22]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/21]AT12.08.2015
DK12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/20]AT12.08.2015
DK12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/14]AT12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/11]AT12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/10]ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/09]FI12.08.2015
LT12.08.2015
LV12.08.2015
GR13.11.2015
Former [2016/07]LT12.08.2015
Documents cited:Search[Y]US5916593  (DE HAAN PIETER [NL], et al) [Y] 13,14 * column 1, lines 4-8 * * column 1, line 41 - column 2, line 7 * * column 2, line 53 - column 3, line 5 * * column 4 - column 6; examples I,IV,VII,VIII,XI *;
 [A]WO9953910  (ORTHO MCNEIL PHARM INC [US], et al) [A] 1-15 * page 6, lines 3-19 * * page 16, lines 1-8 * * page 17, lines 9-18 * * page 17, line 31 - page 18, line 8 ** page 28; example 13 *;
 [Y]WO0115701  (SCHERING AG [DE], et al) [Y] 13,14 * page 1, lines 5-8 * * page 2, lines 25-31 * * page 4, line 11 - page 5, line 16 * * page 11 - page 12; examples 1-3 * * claims 1-45 *;
 [IDY]WO03070255  (PANTARHEI BIOSCIENCE BV [NL], et al) [ID] 1-15 * page 4, paragraphs 2,3 * * page 5, paragraph 3 - page 6, paragraph 3 * * page 13; examples 1,2 * * claims 1-17 * [Y] 13,14;
 [Y]EP1632237  (SCHERING AG [DE]) [Y] 13,14 * page 2, paragraph 13 - page 3, paragraph 20 * * page 4, paragraph 31 * * page 6, paragraph 43 - page 7, paragraph 56 * * page 8, paragraph 70 - page 9, paragraph 72 * * page 11; table 1.2 * * page 12 - page 14; examples 3-5 * * claims 1-19 *
by applicantUS4621079
 US5798338
 US6011040
 US6190693
 US6441168
 EP1253607
 US6610670
 WO03070255
 EP1353700
    - MMWR, MORB. MORTAL. WKLY. REP., (1992), vol. 41, no. RR-14, pages 1 - 7
    - "Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomised, single-dose, 3-way cross-over", EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, (1999), vol. 24, no. 1, pages 47 - 53
    - "Probleme der Dosisfindung: Sexualhormone", PROBLEMS OF DOSE-FINDING: SEX HORMONES
    - F. NEUMANN ET AL., "Arzneimittelforschung", PHARMACEUTICAL AGENT RESEARCH, (1977), vol. 27, 2A, pages 296 - 318
    - "Aktuelle Entwicklungen in der hormonalen Kontrazeption", CURRENT DEVELOPMENTS IN HORMONAL CONTRACEPTION
    - H. KUHL, "Gynakotoge", GYNECOLOGIST, (1992), vol. 25, pages 231 - 240
OppositionWO9609056
 EP1044975
 WO0115701
 WO0152857
 WO03070255
 WO2006120035
 WO2008003432
    - "Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to Calcium L-Methylfolate;", EFSA Journal 2004, (20041123), vol. 135, pages 1 - 20, XP055180628
    - Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, (19990000), pages 209 - 213, XP055293485
    - Handbook of Pharmaceutical Excipients, (20060000), pages 132 - 135
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.